Introduction
Improvements in the quantitative risk assessment of chronic and subchronic exposure to synthetic and natural chemicals and their complex mixtures requires reducing uncertainties associated with exposure as well as all the intermediate steps leading to the adverse effect (i.e., the source-to-outcome continuum) (Kavlock et al. 2003) . Emerging technologies and computational toxicology will provide comprehensive mechanistic information for the development of more quantitative predictive models. However, disparate chemical, exposure, absorption, distribution, metabolism, excretion, toxicologic and omic data, must be integrated to develop more predictive models. To support these efforts throughout the source-to-outcome continuum, innovative software tools are required. Enterprise data management solutions and analysis systems are an integral step in computational toxicology to facilitate mechanistically-based quantitative risk assessments and regulatory decision-making.
Enterprise data management systems have proven to be indispensable in other fields, where they serve as the foundation for data integration across diverse sectors to support large data mining efforts. Similarly toxicology and risk assessment involve combining disparate data throughout the source-to-outcome continuum to identify diagnostic profiles and relationships in susceptible populations and ecologically relevant species. These profiles may represent agglomerative biomarkers encompassing exposure, molecular responses and adverse effects, which facilitate the reevaluation of historical data in light of new information, or allow comparisons across complementary technologies, chemical classes, or species. In addition, relational databases provide the 3 infrastructure to develop computational tools that assist with data interpretation and the elucidation of mechanisms of toxicities.
Various toxicology centric databases and knowledgebases are emerging that provide data management, and facilitate quality assurance, analysis and deposition into public repositories (Bao et al. 2005; Bushel et al. 2001; Hayes et al. 2005; Mattes et al. 2004; Tong et al. 2003; Waters et al. 2003) . In general, they support chemical class comparisons within the same platform (Hayes et al. 2005) , or provide a public repository of genomic data Rocca-Serra et al. 2003) . Although more specific toxicogenomic database efforts are in development, their focus is to support regulatory activities or serve as a public data warehouse (e.g., Chemical Effects in Biological Systems (CEBS) (Waters et al. 2003) ) as opposed to a toxicogenomic laboratory information management systems (LIMS) to support investigator or collaborative group level research efforts prior to publication.
In contrast, the dbZach System is not a public repository, but rather an enterprise computational toxicology analysis and management system developed to support ongoing traditional toxicology and toxicogenomic studies (Figure 1 ), as well as the local development of computational toxicology data mining tools. It complies with the Minimum Information About a Microarray Experiment (MIAME) standard (Brazma et al. 2001) , and the Microarray and Gene Expression (Spellman et al. 2002) Markup Language (MAGE-ML) for electronic data sharing. Although developed for toxicogenomic research efforts, the schematic designs and implementation of dbZach and associated tools are applicable to other biomedical research programs.
To illustrate its functionality, examples of the use of dbZach are provided which can be extrapolated to other independent research efforts. This report communicates the core functionalities of the system, and offers access to the schema and associated tools for establishing independent local installations or the incorporation of select subsystems into other existing databases. Regulation, Pathways, Orthology) ( Fig. 1 and Table 1 ). The modular design reflects biological concepts and relationships to facilitate intuitive interactions and data interpretation. Each module is termed a subsystem, which manages data for a technology (e.g., quantitative Real-Time PCR, spotted microarray, Affymetrix), a biological concept/discipline (e.g., cDNA clones, genes, toxicology, pathway, gene regulation), or a MIAME required concept (e.g., protocols, sample annotation). Its modularity ensures the seamless incorporation of new subsystems for nascent technologies and the adoption of dbZach subsystems into other existing databases.
Database Design
Relationships between tables representing definitive concepts (e.g., animals and organs) are structured to capture relevant biological relationships. For example, the Animal Table records data specific to the animal itself, such as arrival date, age at arrival, sex, and the cage identifier (Figure 2) . A separate table records information about harvested organs, such as the organ name, and weights (e.g., Organ Table under Animal/Biosource). These tables are connected through a one-to-many relationship 5 (depicted as ), where one animal may have associated data from one or more organs. Moreover, organs can be assessed using independent histological sections.
Each section may contain unique lesions that can be identified on a per section basis (e.g., Organ Table has a required one-to-many relationship to Pathology Table as indicated by ). Scores and remarks concerning each lesion (Pathology Lesions Table) are related back to the animal treatment annotation through the Pathology Section
Chemical tables. Thus, chemical treatment/exposure annotation is not provided at every level (e.g., lesion, tissue section, and organ), but only at the animal level. This allows all information regarding experimental manipulations (e.g., route of treatment, surgeries, husbandry) that may influence the outcome (e.g. histopathology) to be associated with the level at which they occurred -the animal. In addition, it optimizes performance and prevents data inconsistencies by reducing redundancy (where this same information would be associated with each experimental level such as histopathology, clinical chemistry, gross observations).
The Subsystems
The following sections describe existing subsystems, and provide specific examples to illustrate the possible supportive roles of dbZach within independent laboratories. The Metabolomic Subsystem was developed in accord with the SMRS standards (Lindon et al. 2005) . Protein, Metabolomic and Pathway subsystems are still in development and will not be discussed in further detail.
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Clones Subsystem
The current implementation of this subsystem manages information for 10,068 human, 25,313 mouse and 8,567 rat cDNA/EST clones used in the preparation of the inhouse custom arrays cataloged within dbZach. Each cDNA clone is associated with one or more GenBank accession numbers to accommodate multiple high probability BLAST matches. It also manages in-house and GenBank sequence information and relates a clone to its location within the 96-or 384-well plates storage plates. The Clones Subsystem can be extended to manage oligonucleotide sets and in situ synthesized oligonucleotide arrays to accommodate laboratories using commercial products (e.g., Agilent arrays, Operon Clone sets).
Genes Subsystem
The Genes Subsystem manages annotation data for 24,837 human (UniGene 
Protocols Subsystem
All protocols and standard operating procedures used within the laboratory are stored within the Protocols Subsystem as required by MIAME. The subsystem follows a hierarchical structure, where the general concept of a protocol resides at the top, and encompasses different versions of a protocol divided into a series of steps to allow tracking of individually implemented modifications through time. This facilitates examination of method differences, to identify biases introduced into a given protocol, or to investigate the effect of varying protocols on data.
Sample Annotation Subsystem
Unlike other MIAME supportive databases, dbZach captures sample annotation as in vivo and in vitro tracks allowing more detailed, less ambiguous information to be managed ( Figure 3 ). The broadest categorization is the project, which includes all experimental data derived from an animal or cell culture model. Data within the animal track includes cage conditions (e.g., bedding material, temperature, light/dark cycle, type of water, feed formulation), sex, age and organs collected, while the in vitro track captures cell culture conditions such as medium formulation, passage number, flask type, and incubator conditions. Our implementation of dbZach currently contains sample annotation data for 815 mice and 484 rats and more than 700 human, mouse and rat in vitro cultures. Both tracks also manage information regarding biological fluids such as serum for clinical chemistry analysis or urine for metabolomics. Information regarding extracted samples used in other assays, such as microarrays or metabolomic profiling of extracted lipids, are also carefully monitored.
This systematic capture of data minimizes redundancy, and ensures proper integration across domains. Fig. 2 illustrates generalization, aggregation, and composition relationships fostered by data integration at the sample annotation level between microarray and pathology data. A generalization is a relationship where common features are shared at a parent node (e.g., Organ), and specific data is captured 8 at child nodes (e.g., specific organs). Aggregations are relationships where one object exists as a collection of other objects, such as a cage is typically an aggregation of animals. Compositions are special aggregations where nonexistence of the collection object precludes existence of the member objects. For example, animals are composed of organs, but if the animal no longer exists within the database, neither can the organs.
Thorough and accurate sample annotation is essential to distinguish subtle differences that may create discrepancies in otherwise comparable studies.
Microarray Subsystem
This subsystem stores the TIFF image from the scanner; the quantified raw data from the analysis of the raw image, and the normalized data. It also tracks the location of all features with respect to pixel locations on the TIFF file and their grid locations. 
Real-Time PCR Subsystem
Storable quantitative real-time PCR (QRT-PCR) data includes forward and reverse primer sequences, the TaqMan probe sequence, assay plate layout information, outputted raw data files, and processed expression data. The primers are associated with the template used for their design, and also with a gene, to provide up-to-date annotation which facilitates comparisons between microarray and QRT-PCR gene expression data.
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The plate layout is critical for monitoring the state of the real-time PCR equipment, and for quality control. There are currently 489 real-time human, mouse and rat PCR primers within this lab's installation. Because this subsystem only manages QRT-PCR data, and is agnostic to the experimental purpose, it can be extended to manage both gene expression and chromatin immunoprecipitation (ChIP) data (Hinojos et al. 2005) .
Toxicology Subsystem
All traditional toxicology data, including histopathology, in vitro assays, and cell morphology is stored within the Toxicology Subsystem and associated with the source organism in the Sample Annotation subsystem.. The National Toxicology Program Pathology Code (Boorman et al. 2002) has been adopted as the controlled vocabulary for pathology data.
Pathology data is stored in a section and lesion centric model where organs are divided into a series of sections, allowing any number of sections to be analyzed. Data are captured per section and lesion, allowing for more comprehensive annotation. This method also facilitates the electronic storage of section micrographs for reassessment or reference. It also supports the creation of pathology image banks for the development of software to computationally identify lesions (Marchevsky and Wick 2004) .
Affymetrix Subsystem
Affymetrix GeneChip data represents another common platform used for global gene expression analysis. A separate subsystem has been created due to the significant differences in platforms, data and file structures relative to two color arrays. All binary format Affymetrix data and images can be parsed and stored within dbZach.
Orthology Subsystem
Orthology is defined as the same entity (e.g., gene) that exists within two distinct species. Knowledge of orthologous relationships is critical for establishing conserved mechanisms of toxicity between species. For example, orthologous genes encode the same protein, and arose from a common ancestor. dbZach catalogues orthologous genes across human, mouse, and rat species, but is species independent, and can be extended to other models including the dog, non-human primate and ecologically-relevant species provided sequence information is available. Orthology relationships may be based on information from a number of databases, although this implementation is specific to the Ensembl database. Currently 155,553 orthologous gene relationships (i.e., 17,047 human-mouse, 16,358 human-rat, and 18,335 mouse-rat orthologous reciprocal best match gene relationships) are managed within dbZach. There are no limits to the number of orthologous entries with respect to species or entity type (i.e., genes or proteins).
Gene Regulatory Subsystem
This subsystem provides access to genomic sequence information (e.g., -10Kb upstream, 5' and 3' untranslated regions) for all human, mouse, and rat genes with RefSeq annotation. It also supports the identification of motifs that may serve important regulatory functions. In general, there are no restrictions regarding what sequence information can be stored.
Implementation Platform Independence
The dbZach system is not designed for any particular RDBMS or operating system. The database schemas are platform agnostic, and have been replicated in Oracle 9i and 10g as well as IBM's DB2. Interaction and data analysis software have been developed in Java (i.e., and require at least version 1.5.0 of the JRE).
Bulk Data Insertions
Data are inserted using template spreadsheet files in MS Excel format. This format was chosen to facilitate bulk uploads as opposed to more involved graphical user interfaces (GUIs) and takes advantage of user familiarity with spreadsheets.
Furthermore, template spreadsheets can be populated by cutting-and-pasting data from other files, simplifying the numerous one-to-many relationships present within data. For example, it is easier to visualize and enter data from one-to-many relationships in a single spreadsheet while minimizing user-based errors, such as typographical errors, or mouseclick errors in the case of GUI combo boxes. Moreover, spreadsheets can record multiple data records, and allow larger datasets to be simultaneously uploaded, thereby decreasing user interaction time. Following submissions, the Audit and Report Tools (ART) generate inspection reports to ensure the data have been faithfully loaded prior to further analysis. This allows data generators, the ones who know the data best, to act as their own curators.
Quality Assurance
Databases serve as a rich source of data for generating quality assurance protocols. As the volume of information increases, a large pool of training data becomes available for the development of automated quality assurance and process control methods which provide non-biased quality assessments. Data within dbZach have been used to establish a protocol that ensures the consistency of microarray data across studies and between investigators in order to maintain intralaboratory quality standards. The protocol combines:1) diagnostic plots monitoring the degree of feature saturation, global feature and background intensities, and feature misalignments with 2) plots monitoring the intensity distributions within arrays and 3) a support vector machine (SVM) model to identify high and low quality microarray data sets .
Database Querying
Databases provide the ability to effectively mine large datasets and identify relationships across domains and experiments. For example, a database can identify all active genes following the same treatment in different tissues or models, supporting hypothesis development regarding a putative mechanism of action. Similarly, queries of histopathology data may identify treatments that yield comparable lesions across tissues and/or species providing compelling evidence for a conserved mechanism of action, thus supporting cross species extrapolations in quantitative risk assessment. Therefore, databases provide the necessary infrastructure to begin to integrate disparate data and provide an effective solution to facilitate investigational queries across different studies.
Structured Query Language (SQL) is used by specific applications and tools that have been developed to interact with dbZach. Most investigator queries occur through 13 Java interfaces and applications built on the Swing library of classes for GUI development (Table 2 ). This implementation of dbZach also includes limited public web access to genes represented on human, mouse and rat cDNA arrays, information regarding our real-time PCR primer library, and routine protocols used in this laboratory.
dbZach Applications in Toxicogenomics
Although queries identify relationships, the output may span several hundred records, making interpretation too complex using standard approaches. Consequently, The TCT has been used to identify similarities and differences in orthologous gene expression in hepatic time course experiments conducted in rats and mice using comparable study designs and treatment regimens ( Figure 4A ). Each point represents correlation values represented as the Activity Index (AI, correlation of rat vs. mouse gene expression profiles) and Significance Index (SI, correlation of rat vs. mouse P1(t) values at each time point) when comparing rat and mouse hepatic time courses in response to ethynyl estradiol (Kwekel et al., 2005) . If the rat and mouse profiles are similar for the orthologous gene, both the AI and SI will be positive (Figure 4, AQ1 and BQ1) . Points within the upper right hand quadrant (quadrants are numbered counter-clockwise with this one denoted: Q1 in Figure 4A ) represent orthologous genes that exhibit profiles with comparable expression patterns and significance profiles suggesting a common mechanism of regulation in both species. In contrast, points in the upper left hand quadrant (QII in Figure 4A ) represent orthologous genes exhibiting divergent expression profiles with comparable P1(t) profiles ( Figure 4B Q2 ). This indicates that the mouse and rat gene expression profiles are different, but they have similar probability profiles.
Quadrant III represents orthologous mouse and rat genes with different expression and significance (P1(t)) patterns ( Figure 4D Q3 ). In quadrant IV orthologous genes have similar expression patterns but exhibit divergent P1(t) values ( Figure 4D Q4 ).
Orthologous genes with dissimilar gene expression patterns in mouse and rat hepatic samples and high P1(t) variability would fall in close proximity to the origin. Points in QII, QIII and QIV as well as those close to the origin may represent orthologous genes with differences in gene regulation that imparts a species specific advantage or sensitivity, and/or species differences in pharmacokinetics and pharmacodynamics. AI and SI divergence may also be due to experimental factors such as rat and mouse probes querying different regions of gene, splice variant present in only one species, and/or inaccurate annotation such that the genes are not true orthologs.
Other data analysis and interpretation applications in development includes tools to identify highly represented functional gene categories, over-represented sequences within gene regulatory regions of similarly expressed genes, and novel visualization tools for the analysis of large pathology datasets.
Data Sharing
Growing interest in data sharing (Ball et al. 2004b; Brazma et al. 2001 ) and calls for the deposition of published data into public repositories (Ball et al. 2004a) , requires effective methods for data exchange. dbZach facilitates sharing by exporting data in the Microarray and Gene Expression (MAGE) Markup Language (MAGE-ML) format (Spellman et al. 2002) between databases, including ArrayExpress Rocca-Serra et al. 2003) , the Gene Expression Omnibus (GEO), and eventually the Chemical Effects in Biological Systems (CEBS) Knowledgebase (Waters et al. 2003) .
Exporting MIAME-compliant data in MAGE-ML has the advantage of being less error prone than web-interaction based submissions since the data are written directly to a file without human intervention.
dbZach Supports Toxicogenomic Research
Toxicogenomic studies may be divided into 1) subject treatment and biological fluid and organ collection (in vivo) or biological sample harvesting (in vitro), 2) microarray assay, 3) gene functional analysis, and 4) phenotypic anchoring ( Figure 5) . dbZach supports each level and facilitates adherence to generally accepted reporting and exchange standards, such as MIAME. Several published and ongoing studies have benefited from the support provided by dbZach Boverhof et al. 2004; Burgoon et al. 2005; Fong et al. 2005; Kwekel et al. 2005) .
In all of these studies, dbZach supported subject treatment and collection including cataloging sample annotation, and information about reagents, husbandry, and growth conditions. It also maintained records of body and organ weights as well as comments regarding gross observations. All of the submitted information is verified using an audit and report tool. Pre-hybridization (e.g. array print date, labeled extract information), hybridization (e.g., RNA amounts, incubation times, washing conditions), and post-hybridization (e.g scanning protocols) are all captured,to facilitate comparisons between studies.
Raw intensity data uploaded to dbZach are first verified by the submitter using the Microarray Audit Report Tool (MART) prior to the quality assurance analysis . Next, a standardized, unattended SAS application is executed that directly interacts with dbZach to extract the required data to identify significant changes in gene expression, thus decreasing statistical analysis time and ensuring all data is properly submitted and analyzed using a consistent protocol to facilitate future study comparisons (e.g., ethynyl estradiol versus tamoxifen; rat versus mouse versus human; in vitro versus in vivo).
In these studies dbZach was also queried for up-to-date functional annotation on differentially expressed genes using the Gene Annotation Tool (GAT). GAT provides a frequency distribution of functions that provides initial insights into pathways perturbed by treatment. For instance, the functional annotation of differentially expressed hepatic genes in C57BL/6 mice treated with TCDD were associated with physiological processes involving oxidative stress, metabolism, differentiation, apoptosis, gluconeogenesis, and fatty acid uptake and metabolism , while in the same model treated with ethynyl estradiol the functional annotation was associated with growth and proliferation, cytoskeletal and extracellular matrix responses, microtubule-based processes, oxidative metabolism and stress, and lipid metabolism and transport . This bring some organization and priority to the list of differentially expressed genes that allow investigators to further elucidate the mechanisms involved by initially focusing on these disrupted pathways.
Consistent acquisition and proper management of these large data sets also allows more comprehensive and systematic comparisons to be performed. dbZach facilitates these comparisons by providing the information necessary to determine if comparable protocols and analysis methods were used. In addition, specific dbZach subsystems and associated tools support the comparative studies and provide visualization tools to assist with interpretation. For example, the availability of microarray and QRTPCR data within dbZach allows comparisons for verification purposes. Moreover, the Orthology Subsystem provides information to facilitate cross-species comparisons in support of risk assessment by assessing extrapolations between species.
A comparison of uterotropic gene expression program in C57BL/6 mice and Sprague-Dawley rats identified 153 orthologous gene pairs that were positively correlated, suggesting these conserved transcriptional targets are important in uterine proliferation. Furthermore, functional annotation for these conserved responses were associated with angiogenesis, water and solute transport, cell cycle control, redox control, DNA replication, protein synthesis and transport, xenobiotic metabolism, cell-cell communication, energetics, and cholesterol and fatty acid regulation, consist with complementary histopathology and morphometry that was also stored within dbZach (Kwekel et al. 2005) .
Current efforts are expanding these capabilities to utilize the the rich information available from the human, mouse and rat genome databases and to incorporate more sophisticated bioinformatic approaches to support mechanistic research. Genomic sequence information has been computationally searched and compared to identify putative dioxin response elements (DREs) in orthologous human, mouse and rat genes and subsequently integrated with gene expression data (Sun et al. 2004) . Results from this study suggest that AhR-mediated gene expression may not be well conserved across species, which could have significant implications in risk assessment. Unsupervised search algorithms are also being developed to identiy novel over-represented response elements in co-regulated genes in an effort to identify interactions between pathways relevant to toxicity.
Consequently, dbZach has driven the development of new software applications that moves beyond the analysis of individual chemicals, species and organs. In addition to data mining and cataloging capabilities, dbZach also serves as a platform for laboratory-wide quality assurance. Furthermore, its reporting applications facilitate the deposition of this information into public repositories.
Conclusion
dbZach serves as a platform for the comprehensive management and integration of disparate data domains facilitating not only the phenotypic anchoring of "omic" data, but also the development of advanced analysis methods, quality assurance protocols, predictive toxicology tools and the systematic examination of mechanisms of toxicity.
These capabilities are currently being extended to include metabonomic data, with proteomic and pathway capabilities in development. Furthermore, dbZach supports the integration of toxicology, gene expression data, functional annotation, orthology, and genomic motif regulatory information. These efforts will not only facilitate the elucidation of comprehensive mechanisms of toxicity and the identification of mechanistically-based biomarkers, but will also engender computational toxicology, systems toxicology and ultimately, more accurate mechanistically-based quantitative risk assessments. Development: tools and applications that are currently in development or testing. tables since a cage may hold more than one animal, and therefore a one-to-many relationship exists between the CAGE and ANIMAL tables. This allows data specific to the cage (e.g., bedding, feed type, water type) to be separated from the animal. Similar logic follows for treatments, and histopathology data. Relationships between tables are depicted using the crow's feet symbols (the line symbols between tables), where the parent Correlation is a measure of profile shape similarity, and is independent of magnitude. 
